Latest Insider Transactions at Lexicon Pharmaceuticals, Inc. (LXRX)
This section provides a real-time view of insider transactions for Lexicon Pharmaceuticals, Inc. (LXRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of LEXICON PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of LEXICON PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2021
|
James F Tessmer VP, Finance & Accounting |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+12.53%
|
$36,000
$3.31 P/Share
|
|
Feb 28
2021
|
Lonnel Coats Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
55,038
-11.19%
|
$385,266
$7.19 P/Share
|
|
Feb 28
2021
|
Lonnel Coats Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
192,885
+9.86%
|
-
|
|
Feb 28
2021
|
Brian T Crum SVP, General Counsel & Secr. |
SELL
Payment of exercise price or tax liability
|
Direct |
14,860
-16.79%
|
$104,020
$7.19 P/Share
|
|
Feb 28
2021
|
Brian T Crum SVP, General Counsel & Secr. |
BUY
Exercise of conversion of derivative security
|
Direct |
38,765
+11.13%
|
-
|
|
Feb 28
2021
|
Alan J Main EVP, Innov & Chem Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
20,413
-12.67%
|
$142,891
$7.19 P/Share
|
|
Feb 28
2021
|
Alan J Main EVP, Innov & Chem Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
56,468
+8.9%
|
-
|
|
Feb 28
2021
|
James F Tessmer VP, Finance & Accounting |
SELL
Payment of exercise price or tax liability
|
Direct |
10,765
-11.52%
|
$75,355
$7.19 P/Share
|
|
Feb 28
2021
|
James F Tessmer VP, Finance & Accounting |
BUY
Exercise of conversion of derivative security
|
Direct |
28,316
+7.64%
|
-
|
|
Feb 28
2021
|
Praveen Tyle EVP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
16,560
-12.06%
|
$115,920
$7.19 P/Share
|
|
Feb 28
2021
|
Praveen Tyle EVP, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
68,007
+12.88%
|
-
|
|
Feb 28
2021
|
Jeffrey L Wade President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
26,584
-14.48%
|
$186,088
$7.19 P/Share
|
|
Feb 28
2021
|
Jeffrey L Wade President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
68,109
+9.42%
|
-
|
|
Dec 31
2020
|
C.V. Invus Director |
SELL
Other acquisition or disposition
|
Direct |
4,321,214
-100.0%
|
-
|
|
Dec 16
2020
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
10,937,500
+25.32%
|
$32,812,500
$3.2 P/Share
|
|
Dec 16
2020
|
Artal International S.C.A. |
BUY
Open market or private purchase
|
Indirect |
10,937,500
+25.32%
|
$32,812,500
$3.2 P/Share
|
|
Jun 28
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
57,724
+1.62%
|
$692,688
$12.45 P/Share
|
|
Jun 27
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
125,114
+3.49%
|
$1,501,368
$12.54 P/Share
|
|
Jun 25
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
228,264
+6.41%
|
$2,739,168
$12.95 P/Share
|
|
Jun 22
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
25,461
+0.81%
|
$330,993
$13.36 P/Share
|
|
Jun 21
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
51,600
+1.65%
|
$670,800
$13.27 P/Share
|
|
Jun 20
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
12,391
+0.41%
|
$161,083
$13.28 P/Share
|
|
Jun 19
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
8,982
+0.3%
|
$116,766
$13.45 P/Share
|
|
Jun 18
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
36,584
+1.2%
|
$475,592
$13.06 P/Share
|
|
Jun 14
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
9,200
+0.31%
|
$110,400
$12.66 P/Share
|
|
Jun 12
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
107,023
+3.49%
|
$1,284,276
$12.83 P/Share
|
|
Jun 11
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
98,626
+3.34%
|
$1,183,512
$12.75 P/Share
|
|
Jun 08
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
29,747
+1.07%
|
$356,964
$12.89 P/Share
|
|
Jun 07
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
57,439
+2.06%
|
$689,268
$12.93 P/Share
|
|
Jun 06
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
95,079
+3.44%
|
$1,140,948
$12.58 P/Share
|
|
Jun 05
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
173,121
+6.3%
|
$2,077,452
$12.45 P/Share
|
|
Jun 04
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
121,803
+4.83%
|
$1,461,636
$12.24 P/Share
|
|
Jun 01
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
147,339
+6.07%
|
$1,768,068
$12.22 P/Share
|
|
May 31
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
147,339
+6.47%
|
$1,620,729
$11.62 P/Share
|
|
May 30
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
147,339
+6.92%
|
$1,473,390
$10.32 P/Share
|
|
May 29
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
147,339
+7.43%
|
$1,326,051
$9.84 P/Share
|
|
May 25
2018
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
138,700
+7.59%
|
$1,248,300
$9.62 P/Share
|
|
Nov 17
2017
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
50,000
+3.13%
|
$450,000
$9.85 P/Share
|
|
Nov 15
2017
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
130,727
+8.02%
|
$1,307,270
$10.21 P/Share
|
|
Nov 14
2017
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
215,133
+13.58%
|
$1,936,197
$9.47 P/Share
|
|
Nov 13
2017
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
215,133
+15.71%
|
$1,936,197
$9.75 P/Share
|
|
Nov 10
2017
|
Invus Public Equities, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
145,680
+13.43%
|
$1,311,120
$9.74 P/Share
|